Full Text View
Tabular View
No Study Results Posted
Related Studies
Value of Rituximab in Humoral Chronic Rejection After Renal Transplantation (Rituximab 2006)
This study has been terminated.
( lacking recruitment )
Study NCT00568477   Information provided by Technische Universität München

First Received on December 5, 2007.   Last Updated on September 30, 2009   History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Grafting
Renal Transplantation
Transplantation, Kidney
Chronic Allograft Nephropathy
Additional conditions recognized in this trial
Kidney Diseases
More general conditions related to this trial
Urologic Diseases
Interventions listed in this trial
MabThera
Additional drug interventions recognized in this trial
Rituximab
More general drug interventions related to this trial
Antineoplastic Agents
Antirheumatic Agents
Immunologic Factors
Pharmacologic Actions
Physiological Effects of Drugs
Therapeutic Uses
Sponsors listed in this trial
Technische Universität München
Humboldt-Universität zu Berlin
University of Erlangen-Nürnberg
University Hospital, Essen
University Hospital Freiburg
University of Heidelberg
University of Jena
Transplantationszentrum Köln-Merheim
University of Regensburg
Heinrich-Heine University, Duesseldorf
Martin-Luther-Universität Halle-Wittenberg


Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services